Jury Still Out On Screening For Thyroid Disease - AHRQ Draft Report
This article was originally published in The Gray Sheet
The benefits and harms of screening for subclinical thyroid disease remain inadequately studied, according to a recent draft report from the Agency for Healthcare Research and Quality
You may also be interested in...
Large, randomized trials are needed to determine the probability that treatment will enhance the quality of life for otherwise healthy patients with abnormal thyroid-stimulating hormone (TSH) levels, according to the U.S. Preventive Services Task Force
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.